FarmaMondo is pleased to announce the launch of its brand new website! After months of hard work and dedication, we are delighted to officially announce the launch on February 12, 2019. The new site launch is available and the URL is www.farmamondo.com The updated site includes changes to...

Merck’s Keytruda (Pembrolizumab) showed better results than chemotherapy at improving overall survival among first-line patients with non-small cell lung cancer in a trial whose results were published last Monday. The benefit extended across PD-L1-positive patients in the study, regardless of their level of PD-L1 expression.  Keytruda is the first...

AstraZeneca’s Tagrisso has been approved by FDA as a first-line treatment for patients with metastatic non-small-cell lung cancer characterized by epidermal growth factor receptor (EGFR) mutations. Tagrisso is already approved in the US as a second-line treatment for this subgroup of lung cancer patients, whose disease...

FarmaMondo Team is pleased to inform you that  is attending Pharmagora Paris 2018. PharmagoraPlus has been the single largest conference and exhibition in France dedicated to serving the pharmacy market for over 30 years. The show brings together all major players under one roof including Ordre National des Pharmaciens, pharmacies‘ buying...

FarmaMondo celebrates the recent successful establishment of its subsidiary in Copenhagen covering all 5 Nordic countries representing more than 27 million people. The Nordic expansion comes as a follow up to the successful operations established in Russia since 2015 covering 12 CIS countries. FarmaMondo continues...

Read the full interview, appeared on the magazine Healthcare and Life Sciences Review with our CEO, Mr. Jaron Spigel, regarding the uniqueness of FarmaMondo business model. With two billion people globally – predominantly in low and middle-income countries – having little or no access to medicine, a select group...

FarmaMondo Team is pleased to inform you that also for 2018 is attending Arab Health in Dubai. Arab Health is the largest gathering of healthcare and trade professionals in the MENA region. The 2018 edition of the event is expected to welcome more than 4,200 exhibiting companies and 103,000...

FarmaMondo has recently hosted two days of medical workshops in Saint Petersburg and Moscow on November 9th and 10th 2017, as part of its support for the exclusive managed access program of Dinutuximab beta EUSA to fulfill the unmet medical needs of patients with high-risk neuroblastoma, in all the CIS...

Following the successful and great experience of last 2 years’ participation FarmaMondo will return again to exhibit at EXPOPHARM 2017which will be held in Düsseldorf, Germany from September 13 to September 15, 2017 FarmaMondo Team will be pleased to host you in our stand at Hall 5 booth A-21 to...